Literature DB >> 14871956

Evaluating a new marker's predictive contribution.

Michael W Kattan1.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 14871956     DOI： 10.1158/1078-0432.ccr-03-0061

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  23 in total

1.  Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration.

Authors:  Douglas G Altman; Lisa M McShane; Willi Sauerbrei; Sheila E Taube
Journal:  BMC Med       Date:  2012-05-29       Impact factor: 8.775

2.  Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.

Authors:  Douglas G Altman; Lisa M McShane; Willi Sauerbrei; Sheila E Taube
Journal:  PLoS Med       Date:  2012-05-29       Impact factor: 11.069

Review 3.  Gene expression-based prognostic signatures in lung cancer: ready for clinical use?

Authors:  Jyothi Subramanian; Richard Simon
Journal:  J Natl Cancer Inst       Date:  2010-03-16       Impact factor: 13.506

Review 4.  Predictive and prognostic models in radical prostatectomy candidates: a critical analysis of the literature.

Authors:  Giovanni Lughezzani; Alberto Briganti; Pierre I Karakiewicz; Michael W Kattan; Francesco Montorsi; Shahrokh F Shariat; Andrew J Vickers
Journal:  Eur Urol       Date:  2010-08-06       Impact factor: 20.096

Review 5.  Role of nomograms for prostate cancer in 2007.

Authors:  Felix K-H Chun; Pierre I Karakiewicz; Hartwig Huland; Markus Graefen
Journal:  World J Urol       Date:  2007-02-27       Impact factor: 4.226

Review 6.  What should physicians look for in evaluating prognostic gene-expression signatures?

Authors:  Jyothi Subramanian; Richard Simon
Journal:  Nat Rev Clin Oncol       Date:  2010-04-27       Impact factor: 66.675

Review 7.  Hazard ratios in cancer clinical trials--a primer.

Authors:  Krastan B Blagoev; Julia Wilkerson; Tito Fojo
Journal:  Nat Rev Clin Oncol       Date:  2012-01-31       Impact factor: 66.675

Review 8.  Combining a molecular profile with a clinical and pathological profile: biostatistical considerations.

Authors:  Richard J Sylvester
Journal:  Scand J Urol Nephrol Suppl       Date:  2008-09

9.  Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk.

Authors:  Tamali Bhattacharyya; Stephen J Nicholls; Eric J Topol; Renliang Zhang; Xia Yang; David Schmitt; Xiaoming Fu; Mingyuan Shao; Danielle M Brennan; Stephen G Ellis; Marie-Luise Brennan; Hooman Allayee; Aldons J Lusis; Stanley L Hazen
Journal:  JAMA       Date:  2008-03-19       Impact factor: 56.272

Review 10.  Minimal Residual Disease Evaluation in Childhood Acute Lymphoblastic Leukemia: A Clinical Evidence Review.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2016-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.